no |
title |
author |
magazine |
year |
volume |
issue |
page(s) |
type |
1 |
Atherosclerosis, Acute Coronary Events, and Cholesterol-Lowering: A New Paradigm
|
Rader, Daniel J. |
|
1998 |
1 |
2 |
p. 101-104 4 p. |
article |
2 |
Cardiovascular Disease and Lipoproteins: Available Evidence and Remaining Questions. Reactor Panel and Open Forum
|
Schwartz, J. Sanford |
|
1998 |
1 |
2 |
p. 125-130 6 p. |
article |
3 |
Health and Economic Outcomes Modeling Practices: A Suggested Framework
|
Halpern, Michael T. |
|
1998 |
1 |
2 |
p. 131-147 17 p. |
article |
4 |
Introduction to the ISPOR Lipid Conference
|
Hay, Joel W. |
|
1998 |
1 |
2 |
p. 95-99 5 p. |
article |
5 |
Landmark Trials in Lipid Reduction
|
Brown, W. Virgil |
|
1998 |
1 |
2 |
p. 110-114 5 p. |
article |
6 |
Lipoproteins and Cardiovascular Disease: Biological Basis and Epidemiological Studies
|
Castelli, William |
|
1998 |
1 |
2 |
p. 105-109 5 p. |
article |
7 |
Prevention of Heart Disease: Is LDL Reduction the Outcome of Choice? Absolutely Yes
|
Stein, Evan A. |
|
1998 |
1 |
2 |
p. 115-119 5 p. |
article |
8 |
Prevention of Heart Disease: Is LDL Reduction the Outcome of Choice? No, There Is More
|
Shepherd, J. |
|
1998 |
1 |
2 |
p. 120-124 5 p. |
article |
9 |
Proceedings of the ISPOR Lipid Confrence: Pharmacoeconomics and Outcomes Research Issues of Lipid Therapy. The First General Session: Cardiovascular Disease and Lipoproteins: Available Evidence and Remaining Questions
|
|
|
1998 |
1 |
2 |
p. 100- 1 p. |
article |